Literature DB >> 7943767

The hospital cost (fiscal year 1991/1992) of a simple perioperative allogeneic red blood cell transfusion during elective surgery at Duke University.

D A Lubarsky1, C Hahn, D H Bennett, L R Smith, S J Bredehoeft, H G Klein, J G Reves.   

Abstract

We sought to determine the actual cost to Duke University Medical Center of a perioperative red blood cell transfusion. A recent audit at Duke University Medical Center determined the base average direct and indirect hospital costs for providing a unit of red blood cells. The Transfusion Service's base cost for providing an allogeneic unit of red blood cells was $113.58. To obtain the actual hospital cost of transfusing a unit of red blood cells in the perioperative period, associated costs were calculated and added to the Transfusion Service's base cost. These associated costs included compatibility tests on multiple units per each unit transfused in the perioperative period, performing ABO and Rh typing and antibody screening on samples from patients who were not subsequently transfused, compatibility tests on units not issued, handling costs of units issued but not used, physically administering the blood, and the cost of the recipient contracting an infectious disease or developing a transfusion reaction. These associated costs increased the cost of transfusing an allogeneic unit of red blood cells in the perioperative period to $151.20. Perhaps the techniques described in the study can be used to quantify cost/benefit ratios associated with future changes in transfusion practice.

Entities:  

Mesh:

Year:  1994        PMID: 7943767     DOI: 10.1213/00000539-199410000-00003

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  3 in total

Review 1.  Clinical and economic impact of epoetins in cancer care.

Authors:  Monia Marchetti; Giovanni Barosi
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  Cost of allogeneic and autologous blood transfusion in Canada. Canadian Cost of Transfusion Study Group.

Authors:  R Tretiak; A Laupacis; M Rivière; K McKerracher; E Souêtre
Journal:  CMAJ       Date:  1996-05-15       Impact factor: 8.262

3.  A cost study of postoperative cell salvage in the setting of elective primary hip and knee arthroplasty.

Authors:  Vidya K Rao; Robert Dyga; Christopher Bartels; Jonathan H Waters
Journal:  Transfusion       Date:  2012-02-17       Impact factor: 3.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.